Insider Transactions and Holdings
-
Entity Type
-
Individual
-
Role
-
Chief Operating Officer
-
Stock Symbol
-
MNPR on Nasdaq
Andrew Cittadine - trading volume in the past year for Monopar Therapeutics
Holdings reported by Andrew Cittadine for Monopar Therapeutics
| Class |
Num Shares |
Value |
Price $ |
Transaction Date |
Ownership |
Underlying Class |
Underlying Amount |
| Common Stock |
39.9K |
$269K |
$6.74 |
Sep 30, 2024 |
Direct |
|
|
| Restricted Stock Units |
12.9K |
$9.4K |
$0.73 |
Sep 30, 2024 |
Direct |
Common Stock |
|
| Stock Options |
25K |
|
|
May 22, 2024 |
Direct |
Common Stock |
|
Transactions reported by Andrew Cittadine for Monopar Therapeutics
| Sym |
Class |
Transaction |
% |
Value $ |
* Price $ |
Shares |
Shares After |
Date |
Ownership |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.